The partnership signals a deepening reliance on Shantha Biologics’ aseptic manufacturing capabilities. While the companies have kept the financial terms of the arrangement private, the scope focuses on the technical execution of cartridge filling, a core competency for the Hyderabad firm. Dr. Vishy Chebrol, Director at Shantha Biologics, noted that the collaboration validates the company’s ability to meet rigorous international standards for global healthcare partners.
In section Releases
Shantha Biologics Secures Novo Nordisk Manufacturing Deal
Hyderabad-based Shantha Biologics will begin providing cartridge fill-finish manufacturing services for Novo Nordisk, marking a significant expansion of its contract operations. The agreement leverages the Indian manufacturer’s specialized sterile facilities to support the global pharmaceutical giant’s production requirements under strict regulatory and quality compliance standards.
This deal strengthens the position of Shantha Biologics within the pharmaceutical supply chain, specifically for biologics and specialized sterile products. By aligning with Novo Nordisk, the company reinforces its role as an outsourcing hub for complex manufacturing processes that demand high precision and consistent quality control.
Comments (0)
No comments yet. Be the first!